New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer
Crossref DOI link: https://doi.org/10.1007/s10689-020-00207-z
Published Online: 2020-09-28
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, D. Gareth
Woodward, Emma R.
Text and Data Mining valid from 2020-09-28
Version of Record valid from 2020-09-28
Article History
First Online: 28 September 2020
Compliance with ethical standards
:
: DGE has received travel grants from AstraZeneca.
Free to read: This content has been made available to all.